Company Filing History:
Years Active: 1995
Title: Marie E Dembinsky: Innovator in Cancer Therapy
Introduction
Marie E Dembinsky is a notable inventor based in Frederick, MD (US). She has made significant contributions to the field of cancer research through her innovative work in monoclonal antibodies. Her dedication to improving cancer diagnostics and therapies has positioned her as a key figure in the medical research community.
Latest Patents
Marie E Dembinsky holds a patent for "Tumor associated monoclonal antibodies." This invention relates to monoclonal antibody 88BV59, which is produced by B-cell lines derived from cancer patients who have been actively immunized with autologous tumor antigen. These monoclonal antibodies have potential applications in both diagnostic procedures and therapeutic interventions for human cancers. She has 1 patent to her name.
Career Highlights
Throughout her career, Marie has worked with Akzo Nobel N.V., where she has been able to apply her research in a practical setting. Her work has contributed to advancements in cancer treatment and has garnered attention within the scientific community.
Collaborations
Marie has collaborated with esteemed colleagues, including Michael G Hanna, Jr and Martin V Haspel. These partnerships have further enhanced her research and development efforts in the field of oncology.
Conclusion
Marie E Dembinsky's innovative work in monoclonal antibodies represents a significant advancement in cancer therapy. Her contributions continue to impact the medical field positively, showcasing the importance of research and collaboration in the fight against cancer.